Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

Rebekka Weber(University Hospital Heidelberg), Viktor Umansky(German Cancer Research Center)
Frontiers in Immunology
June 11, 2018
Cited by 548


Related Papers